| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.003 |